AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4. A total of 19 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,081,076 | +128.2% | 10,316,000 | +322.6% | 0.06% | +114.8% |
| Q1 2022 | $2,227,000 | -13.8% | 2,441,000 | -19.7% | 0.03% | +42.1% |
| Q4 2021 | $2,583,000 | +163.8% | 3,039,000 | +182.2% | 0.02% | +137.5% |
| Q3 2021 | $979,000 | +53.7% | 1,077,000 | +68.3% | 0.01% | +33.3% |
| Q2 2021 | $637,000 | – | 640,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 9,100,000 | $8,937,000 | 3.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 174,372,000 | $170,826,000 | 3.40% |
| PFM Health Sciences, LP | 48,150,000 | $47,381,000 | 1.71% |
| DeepCurrents Investment Group LLC | 17,738,000 | $17,424,000 | 0.67% |
| Weiss Asset Management LP | 17,595,000 | $17,263,000 | 0.42% |
| DAFNA Capital Management LLC | 1,500,000 | $1,476,000 | 0.40% |
| Westchester Capital Management, LLC | 3,853,000 | $3,792,000 | 0.11% |
| Calamos Advisors LLC | 15,438,000 | $15,147,000 | 0.07% |
| Verition Fund Management LLC | 10,316,000 | $5,081,076 | 0.06% |
| OAKTREE CAPITAL MANAGEMENT LP | 2,532,000 | $2,491,000 | 0.03% |